These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 27524414)

  • 21. TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway and promoting the epithelial mesenchymal transition.
    Liu SL; Lin HX; Lin CY; Sun XQ; Ye LP; Qiu F; Wen W; Hua X; Wu XQ; Li J; Song LB; Guo L
    Cancer Lett; 2017 Aug; 402():117-130. PubMed ID: 28583847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging roles of Jab1/CSN5 in DNA damage response, DNA repair, and cancer.
    Pan Y; Yang H; Claret FX
    Cancer Biol Ther; 2014 Mar; 15(3):256-62. PubMed ID: 24495954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CSN5/JAB1 suppresses the WNT inhibitor DKK1 in colorectal cancer cells.
    Jumpertz S; Hennes T; Asare Y; Schütz AK; Bernhagen J
    Cell Signal; 2017 Jun; 34():38-46. PubMed ID: 28229932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Let-7d Inhibits Growth and Metastasis in Breast Cancer by Targeting Jab1/Cops5.
    Wei Y; Liu G; Wu B; Yuan Y; Pan Y
    Cell Physiol Biochem; 2018; 47(5):2126-2135. PubMed ID: 29975923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W; Xiao L; Cao C; Hua S; Wu D
    Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CSN5/Jab1 controls multiple events in the mammalian cell cycle.
    Yoshida A; Yoneda-Kato N; Panattoni M; Pardi R; Kato JY
    FEBS Lett; 2010 Nov; 584(22):4545-52. PubMed ID: 20974137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of the cyclin-dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesis.
    Guo H; Jing L; Cheng Y; Atsaves V; Lv Y; Wu T; Su R; Zhang Y; Zhang R; Liu W; Rassidakis GZ; Wei Y; Nan K; Claret FX
    Hepatology; 2016 Mar; 63(3):898-913. PubMed ID: 26606000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of CSN5 promotes the apoptosis of gastric cancer cells through regulating p53-related apoptotic pathways.
    Sang MM; Du WQ; Zhang RY; Zheng JN; Pei DS
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2897-901. PubMed ID: 26048783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Jab1 promotes glioma cell proliferation by regulating Siah1/β-catenin pathway.
    Zhu Y; Qiu Z; Zhang X; Qian F; Wang B; Wang L; Shi H; Yu R
    J Neurooncol; 2017 Jan; 131(1):31-39. PubMed ID: 27640199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. JAB1/CSN5 and the COP9 signalosome. A complex situation.
    Chamovitz DA; Segal D
    EMBO Rep; 2001 Feb; 2(2):96-101. PubMed ID: 11258719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex.
    Tomoda K; Kubota Y; Arata Y; Mori S; Maeda M; Tanaka T; Yoshida M; Yoneda-Kato N; Kato JY
    J Biol Chem; 2002 Jan; 277(3):2302-10. PubMed ID: 11704659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The TGFβ-induced lncRNA TBILA promotes non-small cell lung cancer progression in vitro and in vivo via cis-regulating HGAL and activating S100A7/JAB1 signaling.
    Lu Z; Li Y; Che Y; Huang J; Sun S; Mao S; Lei Y; Li N; Sun N; He J
    Cancer Lett; 2018 Sep; 432():156-168. PubMed ID: 29908210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased expression and prognostic role of cytoplasmic BRSK1 in human breast carcinoma: correlation with Jab1 stability and PI3K/Akt pathway.
    Wang H; Liu XB; Chen JH; Wang QQ; Chen JP; Xu JF; Sheng CY; Ni QC
    Exp Mol Pathol; 2014 Oct; 97(2):191-201. PubMed ID: 25036402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CSN5 isopeptidase activity links COP9 signalosome activation to breast cancer progression.
    Adler AS; Littlepage LE; Lin M; Kawahara TL; Wong DJ; Werb Z; Chang HY
    Cancer Res; 2008 Jan; 68(2):506-15. PubMed ID: 18199546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Jab1/Cops5 contributes to chemoresistance in breast cancer by regulating Rad51.
    Liu G; Yu M; Wu B; Guo S; Huang X; Zhou F; Claret FX; Pan Y
    Cell Signal; 2019 Jan; 53():39-48. PubMed ID: 30244171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of CSN5/JAB1 in Wnt/β-catenin activation in colorectal cancer cells.
    Schütz AK; Hennes T; Jumpertz S; Fuchs S; Bernhagen J
    FEBS Lett; 2012 Jun; 586(11):1645-51. PubMed ID: 22668871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathway.
    Qu JQ; Yi HM; Ye X; Li LN; Zhu JF; Xiao T; Yuan L; Li JY; Wang YY; Feng J; He QY; Lu SS; Yi H; Xiao ZQ
    Oncotarget; 2015 Sep; 6(29):28341-56. PubMed ID: 26314966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Jab1/Cops5: a promising target for cancer diagnosis and therapy.
    Yuan C; Wang D; Liu G; Pan Y
    Int J Clin Oncol; 2021 Jul; 26(7):1159-1169. PubMed ID: 34019195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.
    Lue H; Kapurniotu A; Fingerle-Rowson G; Roger T; Leng L; Thiele M; Calandra T; Bucala R; Bernhagen J
    Cell Signal; 2006 May; 18(5):688-703. PubMed ID: 16122907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TIPE3 hypermethylation correlates with worse prognosis and promotes tumor progression in nasopharyngeal carcinoma.
    Ren XY; Wen X; Li YQ; Zhang J; He QM; Yang XJ; Tang XR; Wang YQ; Zhang PP; Chen XZ; Cheng B; Ma J; Liu N
    J Exp Clin Cancer Res; 2018 Sep; 37(1):227. PubMed ID: 30217224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.